Related Experiment Video
Updated: Mar 26, 2026
09:32
Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
7.8K
Target-oriented therapy: Emerging drugs for atopic dermatitis
Felix Lauffer1, Johannes Ring1,2
1a Department of Dermatology and Allergy , Technical University of Munich , Munich , Germany.
Expert Opinion on Emerging Drugs
|January 26, 2016
Summary
New therapies are emerging for atopic dermatitis (AD), a chronic inflammatory skin condition. Dupilumab, targeting IL-4 and IL-13, shows significant promise in clinical trials for treating AD.
Area of Science:
- Dermatology
- Immunology
- Pharmacology
Background:
- Atopic dermatitis (AD) affects 10-20% of Western populations, causing significant morbidity.
- Patients experience eczematous lesions, intense itch, and sleep disturbances.
- AD often begins in childhood, with a heterogeneous course, and 30% of cases persist into adulthood.
Purpose of the Study:
- To review novel therapeutic options for atopic dermatitis.
- To highlight promising scientific approaches and drugs in development for AD.
Main Methods:
- Review of current research on AD pathogenesis.
- Analysis of clinical trial data for new AD compounds.
- Focus on targets such as Th2 cells, IL-4, IL-13, TSLP, CRTH2, and IgE.
Main Results:
- Significant progress in understanding AD mechanisms.
- Several new compounds are in clinical trials.
- Dupilumab demonstrates convincing efficacy in Phase III studies.
Conclusions:
- The market for AD drugs is becoming active after a long period.
- Dupilumab, an IL-4 and IL-13 receptor antagonist, is a leading candidate.
- Specific drugs for AD promise a new era in dermatological treatment.
Related Concept Videos
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.3K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.3K
01:19Antiasthma Drugs: Leukotriene Modifiers
2.2K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
2.2K
01:26Targets for Drug Action: Overview
11.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
11.2K
02:57Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
02:57Targeted Cancer Therapies
1.7K
1.7K
01:23Antidepressant Drugs: MAOIs and Other Agents
1.2K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.2K